Literature DB >> 24062886

STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme.

Marc J Claeys1, Peter R Sinnaeve, Carl Convens, Philippe Dubois, Jean Boland, Pascal Vranckx, Sofie Gevaert, Antoine de Meester, Patrick Coussement, Herbert De Raedt, Christophe Beauloye, Marc Renard, Christiaan Vrints, Patrick Evrard.   

Abstract

AIMS: Reports examining local ST elevation myocardial infarction (STEMI) networks focused mainly on percutaneous coronary intervention (PCI)-related time issues and outcomes. To validate the concept of STEMI networks in a real-world context, more data are needed on management and outcome of an unselected community based STEMI population. METHODS AND
RESULTS: The current study evaluated reperfusion strategies and in-hospital mortality in 8500 unselected STEMI patients admitted to 47 community hospitals (n=3053) and 25 PCI-capable hospitals (n=5447) in the context of a nationwide STEMI network programme that started in 2007 in Belgium. The distance between the hub and spoke hospitals ranged from 2.2 to 47 km (median 15 km). A propensity score was used to adjust for differences in baseline characteristics. Reperfusion strategy was significantly different with a predominant use of primary PCI (pPCI) in PCI-capable hospitals (93%), compared to a mixed use of pPCI (71%) and thrombolysis (20%) in community hospitals. A door-to-balloon time <120 min was achieved in 83% of community hospitals and in 91% of PCI-capable hospitals (p<0.0001). In-hospital mortality was 7.0% in community hospitals versus 6.7% in PCI-capable hospitals with an adjusted odds ratio of 1.1 (95% confidence interval: 0.8-1.4). Between the periods 2007-2008 and 2009-2010, the pPCI rate in community hospitals increased from 60% to 80%, whereas the proportion of conservatively managed patients decreased from 11.1% to 7.9%.
CONCLUSION: In a STEMI network with >70% use of pPCI, in-hospital mortality was comparable between community hospitals and PCI-capable hospitals. Participation in the STEMI network programme was associated with an increased adherence to reperfusion guidelines over time.

Entities:  

Keywords:  ST elevation myocardial infarction; networks; primary PCI

Year:  2012        PMID: 24062886      PMCID: PMC3760556          DOI: 10.1177/2048872612441579

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  24 in total

1.  Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Robert E O'Connor; Leo Bossaert; Hans-Richard Arntz; Steven C Brooks; Deborah Diercks; Gilson Feitosa-Filho; Jerry P Nolan; Terry L Vanden Hoek; Darren L Walters; Aaron Wong; Michelle Welsford; Karen Woolfrey
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).

Authors:  Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neil; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-02-21       Impact factor: 29.690

3.  Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2.

Authors:  John G Canto; Robert J Zalenski; Joseph P Ornato; William J Rogers; Catarina I Kiefe; David Magid; Michael G Shlipak; Paul D Frederick; Costas G Lambrew; Katherine A Littrell; Hal V Barron
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

Review 4.  An overview of the objectives of and the approaches to propensity score analyses.

Authors:  Georg Heinze; Peter Jüni
Journal:  Eur Heart J       Date:  2011-02-28       Impact factor: 29.983

5.  Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction.

Authors:  Jacob Thorsted Sørensen; Christian Juhl Terkelsen; Bjarne Linde Nørgaard; Sven Trautner; Troels Martin Hansen; Hans Erik Bøtker; Jens Flensted Lassen; Henning Rud Andersen
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

6.  Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.

Authors:  Brahmajee K Nallamothu; Eric R Bates; Jeph Herrin; Yongfei Wang; Elizabeth H Bradley; Harlan M Krumholz
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

7.  Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).

Authors:  Henning Rud Andersen; Torsten Toftegaard Nielsen; Thomas Vesterlund; Peer Grande; Ulrik Abildgaard; Per Thayssen; Flemming Pedersen; Leif Spange Mortensen
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

8.  Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.

Authors:  C Michael Gibson; Yuri B Pride; Paul D Frederick; Charles V Pollack; John G Canto; Alan J Tiefenbrunn; W Douglas Weaver; Costas T Lambrew; William J French; Eric D Peterson; William J Rogers
Journal:  Am Heart J       Date:  2008-11-01       Impact factor: 4.749

9.  Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors:  M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more
  4 in total

1.  Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011.

Authors:  Dragana Radovanovic; Bramajee K Nallamothu; Burkhardt Seifert; Osmund Bertel; Franz Eberli; Philip Urban; Giovanni Pedrazzini; Hans Rickli; Jean-Christophe Stauffer; Stephan Windecker; Paul Erne
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

2.  Exploring the treatment delay in the care of patients with ST-elevation myocardial infarction undergoing acute percutaneous coronary intervention: a cross-sectional study.

Authors:  Joppe Tra; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  BMC Health Serv Res       Date:  2015-08-21       Impact factor: 2.655

3.  Current Trends for ST-segment Elevation Myocardial Infarction during the Past 5 Years in Rural Areas of China's Liaoning Province: A Multicenter Study.

Authors:  Guang-Xiao Li; Bo Zhou; Guo-Xian Qi; Bo Zhang; Da-Ming Jiang; Gui-Mei Wu; Bing Ma; Peng Zhang; Qiong-Rui Zhao; Juan Li; Ying Li; Jing-Pu Shi
Journal:  Chin Med J (Engl)       Date:  2017-04-05       Impact factor: 2.628

4.  Protocol for a prospective, controlled study of assertive and timely reperfusion for patients with ST-segment elevation myocardial infarction in Tamil Nadu: the TN-STEMI programme.

Authors:  Thomas Alexander; Suma M Victor; Ajit S Mullasari; Ganesh Veerasekar; Kala Subramaniam; Brahmajee K Nallamothu
Journal:  BMJ Open       Date:  2013-12-02       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.